Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 1 7 2020
medline: 16 12 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

Background Deep gray matter structures in patients with Alzheimer disease (AD) contain higher brain iron concentrations. However, few studies have included neocortical areas, which are challenging to assess with MRI. Purpose To investigate baseline and change in brain iron levels using MRI at 3 T with R2* relaxation rate mapping in individuals with AD compared with healthy control (HC) participants. Materials and Methods In this prospective study, participants with AD recruited between 2010 and 2016 and age-matched HC participants selected from 2010 to 2014 were evaluated. Of 100 participants with AD, 56 underwent subsequent neuropsychological testing and brain MRI at a mean follow-up of 17 months. All participants underwent 3-T MRI, including R2* mapping corrected for macroscopic B0 field inhomogeneities. Anatomic structures were segmented, and median R2* values were calculated in the neocortex and cortical lobes, basal ganglia (BG), hippocampi, and thalami. Multivariable linear regression analysis was applied to study the difference in R2* levels between groups and the association between longitudinal changes in R2* values and cognition in the AD group. Results A total of 100 participants with AD (mean age, 73 years ± 9 [standard deviation]; 58 women) and 100 age-matched HC participants (mean age, 73 years ± 9; 60 women) were evaluated. Median R2* levels were higher in the AD group than in the HC group in the BG (HC, 29.0 sec

Identifiants

pubmed: 32602825
doi: 10.1148/radiol.2020192541
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

619-626

Subventions

Organisme : Austrian Science Fund FWF
ID : I 2889
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : KLI 523
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 30134
Pays : Austria

Auteurs

Anna Damulina (A)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Lukas Pirpamer (L)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Martin Soellradl (M)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Maximilian Sackl (M)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Christian Tinauer (C)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Edith Hofer (E)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Christian Enzinger (C)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Benno Gesierich (B)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Marco Duering (M)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Stefan Ropele (S)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Reinhold Schmidt (R)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Christian Langkammer (C)

From the Department of Neurology (A.D., L.P., M. Soellradl, M. Sackl, C.T., E.H., C.E., S.R., R.S., C.L.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Division of Neuroradiology, Vascular, and Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Auenbruggerplatz 22, 8036 Graz, Austria; and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany (B.G., M.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH